# A viable kinase-inactive RIPK3 D143N mouse model reveals its scaffold function in driving TNF-induced inflammatory disorder

**Authors:** Yayun Du, Jingjing Li, Cong Zhao, Shouqiao Hou, Qiuye Li, Xiangping Xu, Zhanhui Li, Jiaying Qiu, Changyu Zhuang, Lifen Xie, Feng Ma, Xiaohu Zhang, Xiaoliang Yu, Sudan He

PMC · DOI: 10.1038/s41420-026-02962-x · 2026-02-24

## TL;DR

A new mouse model shows that RIPK3's non-kinase function promotes inflammation, offering insights into treating inflammatory diseases.

## Contribution

A viable kinase-inactive RIPK3 mouse model reveals its scaffold role in inflammation without affecting development.

## Key findings

- Ripk3D143N/D143N mice are viable and fertile, showing kinase activity is not essential for development.
- The RIPK3 D143N mutation blocks necroptosis and rescues embryonic lethality in caspase-8-deficient mice.
- RIPK3's scaffold function drives inflammation via JAK-STAT1, reduced by JAK1/2 inhibition.

## Abstract

RIPK3 is a key regulator of necroptosis, but the specific roles of its kinase-dependent and -independent functions in disease pathogenesis remain poorly understood. Here, we generated and characterized RIPK3 D143N kinase-dead knock-in mice, a novel kinase-inactive model that selectively disrupts RIPK3 kinase activity without inducing spontaneous apoptosis. Unlike previously reported kinase-inactive Ripk3D161N/D161N mice, which exhibit embryonic lethality by triggering apoptosis, Ripk3D143N/D143N mice are viable and fertile, demonstrating that RIPK3 kinase activity is dispensable for development. The RIPK3 D143N mutation effectively blocks necroptosis induced by multiple stimuli and fully rescues embryonic lethality of caspase-8-deficient mice. Notably, Ripk3D143N/D143N mice were significantly less protected from TNF-driven inflammatory disease than RIPK3-deficient mice, revealing a critical kinase-independent role for RIPK3. This scaffold function drives inflammation and tissue damage through JAK-STAT1 activation, as pharmacological inhibition of JAK1/2 effectively reduces disease pathogenesis. Thus, our findings establish Ripk3D143N/D143N mice as a valuable model for dissecting the kinase and scaffold functions of RIPK3, and highlights the therapeutic potential of targeting its scaffold function in inflammatory diseases.

Schematic diagram showing the kinase-dependent and kinase-independent function in cell death and inflammation. A novel kinase-inactive RIPK3 mouse model (Ripk3D143N/D143N) defines the kinase-dependent and kinase-independent role of RIPK3 in cell death and inflammation.

Schematic diagram showing the kinase-dependent and kinase-independent function in cell death and inflammation. A novel kinase-inactive RIPK3 mouse model (Ripk3D143N/D143N) defines the kinase-dependent and kinase-independent role of RIPK3 in cell death and inflammation.

## Linked entities

- **Genes:** RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035], casp8 (caspase 8, apoptosis-related cysteine peptidase) [NCBI Gene 58022]
- **Proteins:** RIPK3 (receptor interacting serine/threonine kinase 3), JAK1 (Janus kinase 1), JAK2 (Janus kinase 2)
- **Diseases:** inflammatory disorder (MONDO:0021166)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ripk1 (receptor (TNFRSF)-interacting serine-threonine kinase 1) [NCBI Gene 19766] {aka D330015H01Rik, RIP, RIP-1, Rinp, Rip1}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Fadd (Fas associated via death domain) [NCBI Gene 14082] {aka Mort1/FADD}, Rip (regulation of phenobarbitol-inducible P450) [NCBI Gene 110628], Ripk3 (receptor-interacting serine-threonine kinase 3) [NCBI Gene 56532] {aka 2610528K09Rik, Rip3}, Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 20846] {aka 2010005J02Rik}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Zbp1 (Z-DNA binding protein 1) [NCBI Gene 58203] {aka 2010010H03Rik, Dai, Dlm1, mZaDLM}, Diablo (diablo, IAP-binding mitochondrial protein) [NCBI Gene 66593] {aka 0610041G12Rik, 1700006L01Rik, Smac}, Casp8 (caspase 8) [NCBI Gene 12370] {aka CASP-8, FLICE, MACH, Mch5}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Parp1 (poly (ADP-ribose) polymerase family, member 1) [NCBI Gene 11545] {aka 5830444G22Rik, ARTD1, Adprp, Adprt1, PARP, PPOL}, Casp9 (caspase 9) [NCBI Gene 12371] {aka APAF-3, CASP-9, Caspase-9, ICE-LAP6, Mch6}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Mlkl (mixed lineage kinase domain-like) [NCBI Gene 74568] {aka 9130019I15Rik}, Jak1 (Janus kinase 1) [NCBI Gene 16451] {aka BAP004, C130039L05Rik}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Tnfrsf1b (tumor necrosis factor receptor superfamily, member 1b) [NCBI Gene 21938] {aka CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR}, Casp7 (caspase 7) [NCBI Gene 12369] {aka CMH-1, ICE-IAP3, Mch3, caspase-7, mCASP-7}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Cort (cortistatin) [NCBI Gene 12854] {aka CST, PCST}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, DIABLO (diablo IAP-binding mitochondrial protein) [NCBI Gene 56616] {aka DFNA64, SMAC}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}
- **Diseases:** SIRS (MESH:D018746), GVHD (MESH:D006086), acute pancreatitis (MESH:D010195), shock (MESH:D012769), neurodegenerative diseases (MESH:D019636), Inflammation (MESH:D007249), IAV infection (MESH:D007251), cervical carcinoma (MESH:D002583), necrosis (MESH:D009336), sepsis (MESH:D018805), cecal injury (MESH:D002429), ALS (MESH:D008113), tissue damage (MESH:D017695), kidney and heart ischemia- (MESH:D007674), pathological damage (MESH:D005598), amyotrophic lateral sclerosis (MESH:D000690), reperfusion injury (MESH:D015427), hypothermia (MESH:D007035), embryonic lethality (MESH:D020964)
- **Chemicals:** PEG400 (MESH:C000595213), Ruxolitinib (MESH:C540383), L (MESH:D007930), TRIzol (MESH:C411644), Poly(I:C) (MESH:D011070), C (MESH:D002244), streptomycin (MESH:D013307), SCH772984 (MESH:C587178), Triton X-100 (MESH:D017830), T (MESH:D014316), NaCl (MESH:D012965), paraffin (MESH:D010232), P (MESH:D010758), PBS (MESH:D007854), Z (MESH:C000597310), Cremophor EL (MESH:C000515), DMSO (MESH:D004121), CO2 (MESH:D002245), ATP (MESH:D000255), GSK'872 (MESH:C000633405), LPS (MESH:D008070), beta-glycerol phosphate (MESH:C031463), S (MESH:D013455), H&amp;E (MESH:D006371), D143N (-), PI (MESH:D011419), glycerol (MESH:D005990), penicillin (MESH:D010406)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** D142N, D160N, D161N, D143, D161N, K51A, D143N
- **Cell lines:** 293 T — Homo sapiens (Human), Transformed cell line (CVCL_0063), MEFs — Mus musculus (Mouse), Finite cell line (CVCL_9115), Ripk3D143N — Homo sapiens (Human), Xeroderma pigmentosum, Finite cell line (CVCL_ZR67), HSV-1 — Homo sapiens (Human), Transformed cell line (CVCL_G005), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), 3T3-SA — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), MEF — Mus musculus (Mouse), Transformed cell line (CVCL_4240)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966316/full.md

---
Source: https://tomesphere.com/paper/PMC12966316